Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial. (2016)
Attributed to:
Statistical ‘omics approaches to understanding autoimmune diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.6039
Publication URI: https://www.repository.cam.ac.uk/handle/1810/260877
Type: Journal Article/Review